Detalles de la búsqueda
1.
Reproducibility of the T-SPOT.TB test for screening Mycobacterium tuberculosis infection in Japan.
J Infect Chemother
; 26(2): 194-198, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31495568
2.
Real-world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non-small cell lung cancer.
Thorac Cancer
; 15(15): 1208-1217, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38602166
3.
Atezolizumab addition to platinum doublet: evaluating survival outcomes for patients with extensive disease small cell lung cancer.
J Cancer Res Clin Oncol
; 149(19): 17419-17426, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37878090
4.
Thymic atypical carcinoid tumors with elevated mitotic counts in a patient with multiple endocrine neoplasia: A case report.
Thorac Cancer
; 14(14): 1311-1315, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36941083
5.
Primary tracheal small-cell carcinoma detected 11 months after surgery for pulmonary large-cell neuroendocrine carcinoma: A case report.
Thorac Cancer
; 14(13): 1212-1216, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36977572
6.
Tailoring Therapeutic Strategies in Non-Small-Cell Lung Cancer: The Role of Genetic Mutations and Programmed Death Ligand-1 Expression in Survival Outcomes.
Cancers (Basel)
; 15(21)2023 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37958421
7.
Comparison of the slow-pull and aspiration methods of endobronchial ultrasound-guided transbronchial needle aspiration for next-generation sequencing-compatible tissue collection in non-small cell lung cancer.
Cancer Med
; 12(19): 19512-19522, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37732488
8.
Predictors of lung injury during durvalumab maintenance therapy following concurrent chemoradiotherapy in unresectable locally advanced non-small cell lung carcinoma.
Thorac Cancer
; 14(25): 2601-2607, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37533115
9.
Combination of Pembrolizumab With Platinum-containing Chemotherapy for Pulmonary Enteric Adenocarcinoma.
Cancer Diagn Progn
; 2(2): 253-257, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35399182
10.
Retrospective analysis of independent predictors of progression-free survival in patients with EGFR mutation-positive advanced non-small cell lung cancer receiving first-line osimertinib.
Thorac Cancer
; 13(19): 2741-2750, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36082812
11.
Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non-small-cell lung cancer: A multicenter retrospective trial.
Thorac Cancer
; 13(2): 228-235, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34866339
12.
Nivolumab-induced Vogt-Koyanagi-Harada-like Syndrome and Adrenocortical Insufficiency with Long-term Survival in a Patient with Non-small-cell Lung Cancer.
Intern Med
; 60(22): 3593-3598, 2021 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34092725
13.
T-cell response to phytohemagglutinin in the interferon-γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non-small cell lung cancer.
Thorac Cancer
; 12(11): 1726-1734, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33943031
14.
Class A CpG oligodeoxynucleotide inhibits IFN-γ-induced signaling and apoptosis in lung cancer.
Thorac Cancer
; 11(4): 983-992, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32067413
15.
Identification of a novel biomarker based on lymphocyte count, albumin level, and TBAg/PHA ratio for differentiation between active and latent tuberculosis infection in Japan.
Tuberculosis (Edinb)
; 125: 101992, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32957053
16.
Identification of Biomarkers for Non-small-cell Lung Cancer Patients Treated With an Immune Checkpoint Inhibitor.
Anticancer Res
; 40(7): 3889-3896, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32620629
17.
MicroRNA-200b is a potential biomarker of the expression of PD-L1 in patients with lung cancer.
Thorac Cancer
; 11(10): 2975-2982, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32893980
18.
Afatinib + bevacizumab combination therapy in EGFR-mutant NSCLC patients with osimertinib resistance: Protocol of an open-label, phase II, multicenter, single-arm trial.
Thorac Cancer
; 11(8): 2125-2129, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32495514
Resultados
1 -
18
de 18
1
Próxima >
>>